Sera Prognostics (SERA) IPO Opens Lower

Today's IPO for Sera Prognostics Inc. (NASDAQ: SERA) opened for trading at $15.10 after pricing 4,687,500 shares of its common stock at a price to the public of $16.00 per share.

Citigroup Global Markets Inc., Cowen and Company, LLC and William Blair & Company, L.L.C. are acting as the joint book-running managers for this offering.

Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera’s PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Sera is located in Salt Lake City, Utah.

You May Also Be Interested In

• Quantinuum (QNT) opens at $68, 13% above IPO pricing
• Anthropic president cites high capital needs as key motive for IPO
• William Blair on Affirm Holdings (AFRM): 'among our best digital finance ideas'